Health Catalyst, Inc. (NASDAQ:HCAT) Given Consensus Rating of “Moderate Buy” by Brokerages

Shares of Health Catalyst, Inc. (NASDAQ:HCAT) have earned an average recommendation of “Moderate Buy” from the eleven brokerages that are presently covering the firm, Marketbeat.com reports. Three analysts have rated the stock with a hold recommendation and eight have given a buy recommendation to the company. The average 1-year price target among brokerages that have issued a report on the stock in the last year is $12.09.

A number of research analysts have recently commented on the stock. KeyCorp reaffirmed a “sector weight” rating on shares of Health Catalyst in a research report on Wednesday, April 10th. Piper Sandler cut their price objective on shares of Health Catalyst from $15.00 to $14.00 and set an “overweight” rating for the company in a research report on Thursday, June 6th. Cantor Fitzgerald reissued an “overweight” rating and issued a $16.00 price target on shares of Health Catalyst in a research report on Wednesday, April 10th. Wells Fargo & Company dropped their price target on shares of Health Catalyst from $14.00 to $13.00 and set an “overweight” rating for the company in a research report on Friday, May 10th. Finally, Canaccord Genuity Group reissued a “buy” rating and issued a $11.00 price target on shares of Health Catalyst in a research report on Tuesday, May 21st.

Institutional Trading of Health Catalyst

A number of institutional investors have recently bought and sold shares of the business. EntryPoint Capital LLC acquired a new position in shares of Health Catalyst in the 1st quarter valued at approximately $98,000. Los Angeles Capital Management LLC acquired a new position in Health Catalyst during the 4th quarter worth approximately $108,000. Tower Research Capital LLC TRC increased its position in Health Catalyst by 285.4% during the 4th quarter. Tower Research Capital LLC TRC now owns 12,018 shares of the company’s stock worth $111,000 after purchasing an additional 8,900 shares in the last quarter. Virtus Investment Advisers Inc. acquired a new position in Health Catalyst during the 1st quarter worth approximately $115,000. Finally, MQS Management LLC acquired a new position in Health Catalyst in the 3rd quarter valued at approximately $116,000. Institutional investors own 85.00% of the company’s stock.

Health Catalyst Stock Performance

NASDAQ HCAT opened at $6.05 on Friday. The stock has a market capitalization of $357.13 million, a P/E ratio of -3.27 and a beta of 1.32. Health Catalyst has a 1 year low of $5.45 and a 1 year high of $14.37. The business’s fifty day moving average is $6.44 and its two-hundred day moving average is $7.93.

Health Catalyst (NASDAQ:HCAT) last posted its quarterly earnings results on Thursday, May 9th. The company reported ($0.14) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.19) by $0.05. Health Catalyst had a negative net margin of 35.56% and a negative return on equity of 11.86%. The business had revenue of $74.72 million for the quarter, compared to the consensus estimate of $74.81 million. On average, research analysts forecast that Health Catalyst will post -0.4 earnings per share for the current year.

Health Catalyst Company Profile

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.